Levana Sherman

2.3k total citations
50 papers, 1.9k citations indexed

About

Levana Sherman is a scholar working on Epidemiology, Molecular Biology and Genetics. According to data from OpenAlex, Levana Sherman has authored 50 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 21 papers in Molecular Biology and 18 papers in Genetics. Recurrent topics in Levana Sherman's work include Cervical Cancer and HPV Research (20 papers), Virus-based gene therapy research (17 papers) and Molecular Biology Techniques and Applications (9 papers). Levana Sherman is often cited by papers focused on Cervical Cancer and HPV Research (20 papers), Virus-based gene therapy research (17 papers) and Molecular Biology Techniques and Applications (9 papers). Levana Sherman collaborates with scholars based in Israel, United States and France. Levana Sherman's co-authors include Richard Schlegel, N. Dafni, Yoram Groner, Anna Jackman, J. Lieman-Hurwitz, A. Yaniv, Steven R. Tronick, Arnona Gazit, Ditsa Levanon and Hava Lichtig and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Levana Sherman

50 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Levana Sherman Israel 26 822 779 394 312 213 50 1.9k
Ramareddy V. Guntaka United States 25 1.4k 1.6× 326 0.4× 543 1.4× 208 0.7× 244 1.1× 68 2.4k
Shuhong Luo China 29 853 1.0× 795 1.0× 328 0.8× 315 1.0× 410 1.9× 91 2.2k
Yan‐Hwa Wu Lee Taiwan 30 1.8k 2.1× 993 1.3× 241 0.6× 294 0.9× 319 1.5× 82 3.2k
Yoshio Yamakawa Japan 26 1.3k 1.6× 226 0.3× 324 0.8× 117 0.4× 323 1.5× 91 2.3k
Audrey Esclatine France 22 675 0.8× 1.4k 1.8× 179 0.5× 143 0.5× 355 1.7× 33 2.0k
Robert M. Crowl United States 22 1.2k 1.4× 130 0.2× 383 1.0× 256 0.8× 421 2.0× 31 2.2k
Luis L. P. daSilva Brazil 27 1.7k 2.1× 226 0.3× 174 0.4× 338 1.1× 549 2.6× 61 2.9k
Xaveer Van Ostade Belgium 27 1.0k 1.2× 446 0.6× 132 0.3× 311 1.0× 922 4.3× 61 2.3k
Genki Kimura Japan 25 1.1k 1.3× 239 0.3× 492 1.2× 643 2.1× 469 2.2× 129 2.2k
A Senik France 27 1.2k 1.4× 538 0.7× 224 0.6× 405 1.3× 1.6k 7.6× 80 3.2k

Countries citing papers authored by Levana Sherman

Since Specialization
Citations

This map shows the geographic impact of Levana Sherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levana Sherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levana Sherman more than expected).

Fields of papers citing papers by Levana Sherman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Levana Sherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levana Sherman. The network helps show where Levana Sherman may publish in the future.

Co-authorship network of co-authors of Levana Sherman

This figure shows the co-authorship network connecting the top 25 collaborators of Levana Sherman. A scholar is included among the top collaborators of Levana Sherman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levana Sherman. Levana Sherman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackman, Anna, et al.. (2017). E6 proteins of α and β cutaneous HPV types differ in their ability to potentiate Wnt signaling. Virology. 509. 11–22. 8 indexed citations
2.
Shapiro, Beny, et al.. (2014). HPV16 E6 and E6AP differentially cooperate to stimulate or augment Wnt signaling. Virology. 468-470. 510–523. 31 indexed citations
3.
Milrot, Elad, Anna Jackman, Eliezer Flescher, et al.. (2012). Enhanced killing of cervical cancer cells by combinations of methyl jasmonate with cisplatin, X or alpha radiation. Investigational New Drugs. 31(2). 333–344. 27 indexed citations
4.
Zehbe, Ingeborg, et al.. (2011). Rare human papillomavirus 16 E6 variants reveal significant oncogenic potential. Molecular Cancer. 10(1). 77–77. 31 indexed citations
5.
Richard, Christina, Carita Lannér, Stanislav Naryzhny, et al.. (2010). The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalences in cervical cancer. Oncogene. 29(23). 3435–3445. 59 indexed citations
6.
Lichtig, Hava, et al.. (2009). HPV16 E6 augments Wnt signaling in an E6AP-dependent manner. Virology. 396(1). 47–58. 55 indexed citations
7.
Jackman, Anna, et al.. (2008). HPV16 E6 oncoprotein increases cell adhesion in human keratinocytes. Archives of Virology. 154(1). 55–63. 1 indexed citations
8.
Zehbe, Ingeborg, Christina Richard, Correne A. DeCarlo, et al.. (2008). Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis. Virology. 383(1). 69–77. 60 indexed citations
9.
Lichtig, Hava, et al.. (2007). Activities of human papillomavirus 16 E6 natural variants in human keratinocytes. Journal of Medical Virology. 79(11). 1751–1760. 36 indexed citations
10.
Lichtig, Hava, et al.. (2006). HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6. Virology. 350(1). 216–227. 60 indexed citations
11.
12.
Jackman, Anna, et al.. (1999). HPV16 E6 Oncoprotein Inhibits Apoptosis Induced during Serum–Calcium Differentiation of Foreskin Human Keratinocytes. Virology. 257(2). 383–396. 40 indexed citations
13.
Schlegel, Richard, et al.. (1998). Induction of apoptosis in human keratinocytes containing mutated p53 alleles and its inhibition by both the E6 and E7 oncoproteins. International Journal of Cancer. 75(1). 96–104. 47 indexed citations
14.
15.
Stöppler, Hubert, Dan-Paul Hartmann, Levana Sherman, & Richard Schlegel. (1997). The Human Papillomavirus Type 16 E6 and E7 Oncoproteins Dissociate Cellular Telomerase Activity from the Maintenance of Telomere Length. Journal of Biological Chemistry. 272(20). 13332–13337. 103 indexed citations
16.
17.
Sherman, Levana & Richard Schlegel. (1996). Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16. Journal of Virology. 70(5). 3269–3279. 101 indexed citations
18.
Kalinski, Hagar, Levana Sherman, Toru Miki, et al.. (1994). Characterization of cDNAs Species Encoding the Tat Protein of Caprine Arthritis Encephalitis Virus. Virology. 204(2). 828–834. 12 indexed citations
19.
20.
Noiman, Silvia, Arnona Gazit, Levana Sherman, et al.. (1990). Identification of sequences encoding the equine infectious anemia virus tat gene. Virology. 176(1). 280–288. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ramareddy V. Guntaka Breakdown of academic impact, for papers by Shuhong Luo Breakdown of academic impact, for papers by Yan‐Hwa Wu Lee Breakdown of academic impact, for papers by Yoshio Yamakawa Breakdown of academic impact, for papers by Audrey Esclatine Breakdown of academic impact, for papers by Robert M. Crowl Breakdown of academic impact, for papers by Luis L. P. daSilva Breakdown of academic impact, for papers by Xaveer Van Ostade Breakdown of academic impact, for papers by Genki Kimura Breakdown of academic impact, for papers by A Senik
Rankless by CCL
2026